» Articles » PMID: 39583976

Characterized Factors of Subjects Who Were First Time Diagnosed As Hyperglycemia More Than 126 mg/dl During Annual or Biannual Medical Checkups: a Case-control Study in Japan

Abstract

The present study examined factors in subjects diagnosed with hyperglycemia during periodic medical checkups. In total, 9,324 subjects (males: 4,532, females: 4,792) visited the Takagi Hospital for medical checkups in 2019. Eighty-two subjects (59 males) whose fasting blood glucose exceeded 126 mg/dl for the first time during the annual or biannual follow-up were included. Sex- and age-matched controls were used. Data from cases with hyperglycemia were compared to data from themselves one or two years before hyperglycemia. Body mass index (BMI), waist circumference, fatty liver, and blood pressure were higher in cases than in controls. Fasting blood glucose and hemoglobin A1c were higher in cases. Blood test results indicated that triglyceride, low-density lipoprotein (LDL) cholesterol, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyl transpeptidase (γ-GTP), were significantly enhanced in cases. Multiple logistic regression analysis revealed that BMI, waist circumference, blood pressure, triglyceride, ALT, and γ-GTP were significant independent risk factors for cases with hyperglycemia. These risk factors were already enhanced in the cases of themselves in one or two years before hyperglycemia. In conclusion, BMI, waist circumference, blood pressure, and fatty liver indicated by ALT and γ-GTP were exacerbated concomitant with hyperglycemia, and increases in these factors preceded hyperglycemia.

References
1.
Eguchi Y, Wong G, Lee E, Akhtar O, Lopes R, Sumida Y . Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review. JGH Open. 2020; 4(5):808-817. PMC: 7578337. DOI: 10.1002/jgh3.12349. View

2.
Fujimoto K, Yamanouchi K, Kishi T . [Role of the gastrointestinal tract on therapeutic approach to obesity]. Nihon Shokakibyo Gakkai Zasshi. 2021; 118(6):500-504. DOI: 10.11405/nisshoshi.118.500. View

3.
Takegami M, Hashimoto Y, Hamaguchi M, Kaji A, Sakai R, Okamura T . Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes. J Clin Biochem Nutr. 2022; 71(2):136-142. PMC: 9519414. DOI: 10.3164/jcbn.21-152. View

4.
Liu J, Mozaffarian D, Sy S, Lee Y, Wilde P, Abrahams-Gessel S . Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study. Circ Cardiovasc Qual Outcomes. 2020; 13(6):e006313. PMC: 7299757. DOI: 10.1161/CIRCOUTCOMES.119.006313. View

5.
Mikami K, Endo T, Sawada N, Igarashi G, Kimura M, Hasegawa T . Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project. J Clin Biochem Nutr. 2022; 70(3):273-282. PMC: 9130064. DOI: 10.3164/jcbn.21-61. View